Mindmed co-founder dr. scott freeman proposes value enhancement plan

Sheridan, wyo. , aug. 11, 2022 /prnewswire/ -- today, fcm mm holdings, llc ("fcm") announced that it has sent a letter to the board of directors of mind medicine (mindmed) inc. (nasdaq:mnmd) (the "company" or "mindmed") calling on the board to adopt a new strategic plan proposed by fcm including: refocusing on its core drugs, cutting cash burn, and terminating mindmed's at-the-money equity offering.
MNMD Ratings Summary
MNMD Quant Ranking